These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 20868469)

  • 1. Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems - an observational cohort study.
    Huss M; Völp A; Stauss-Grabo M
    Lipids Health Dis; 2010 Sep; 9():105. PubMed ID: 20868469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Leach MJ; Perez Algorta G
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007986. PubMed ID: 37058600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of dietary supplementation with natural ω-3 polyunsaturated fatty acids on the visual acuity of school-age children with lower IQ or attention-deficit hyperactivity disorder.
    Wu Q; Zhou T; Ma L; Yuan D; Peng Y
    Nutrition; 2015; 31(7-8):935-40. PubMed ID: 26015389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
    Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
    Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of Attention-Deficit/Hyperactivity Disorders with polyunsaturated fatty acids - an effective treatment alternative?].
    Frölich J; Döpfner M
    Z Kinder Jugendpsychiatr Psychother; 2008 Mar; 36(2):109-16. PubMed ID: 18622940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
    Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
    Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children.
    Schuchardt JP; Huss M; Stauss-Grabo M; Hahn A
    Eur J Pediatr; 2010 Feb; 169(2):149-64. PubMed ID: 19672626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Omega-3 and omega-6 fatty acids in the treatment of children and adolescents with ADHD].
    Aben A; Danckaerts M
    Tijdschr Psychiatr; 2010; 52(2):89-97. PubMed ID: 20146180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acids in ADHD: plasma profiles in a placebo-controlled study of Omega 3/6 fatty acids in children and adolescents.
    Johnson M; Månsson JE; Ostlund S; Fransson G; Areskoug B; Hjalmarsson K; Landgren M; Kadesjö B; Gillberg C
    Atten Defic Hyperact Disord; 2012 Dec; 4(4):199-204. PubMed ID: 22753087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study.
    Colter AL; Cutler C; Meckling KA
    Nutr J; 2008 Feb; 7():8. PubMed ID: 18275609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
    Parletta N; Niyonsenga T; Duff J
    PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta-analysis.
    Cooper RE; Tye C; Kuntsi J; Vassos E; Asherson P
    J Affect Disord; 2016 Jan; 190():474-482. PubMed ID: 26551407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.
    Rheims S; Herbillon V; Gaillard S; Mercier C; Villeuve N; Villéga F; Cances C; Castelnau P; Napuri S; de Saint-Martin A; Auvin S; Nguyen The Tich S; Berquin P; de Bellecize J; Milh M; Roy P; Arzimanoglou A; Bodennec J; Bezin L; Kassai B;
    Epilepsia Open; 2024 Apr; 9(2):582-591. PubMed ID: 38173190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids.
    Checa-Ros A; Haro-García A; Seiquer I; Molina-Carballo A; Uberos-Fernández J; Muñoz-Hoyos A
    Minerva Pediatr; 2019 Aug; 71(4):313-325. PubMed ID: 30419741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066.
    Kean JD; Camfield D; Sarris J; Kras M; Silberstein R; Scholey A; Stough C
    Nutr J; 2013 Jul; 12():100. PubMed ID: 23866813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional supplements for the treatment of ADHD.
    Bloch MH; Mulqueen J
    Child Adolesc Psychiatr Clin N Am; 2014 Oct; 23(4):883-97. PubMed ID: 25220092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of ω-3 polyunsaturated fatty acids in child development].
    Ozerskaia IV; Khachatryan LG; Kolosova NG; Polyanskaya AV; Kasanave EV
    Vopr Pitan; 2024; 93(2):6-18. PubMed ID: 38809795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid supplementation for children with attention deficit hyperactivity disorder: A comprehensive review of the evidence.
    Ramalho R; Pereira AC; Vicente F; Pereira P
    Clin Nutr ESPEN; 2018 Jun; 25():1-7. PubMed ID: 29779801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder.
    Gow RV; Matsudaira T; Taylor E; Rubia K; Crawford M; Ghebremeskel K; Ibrahimovic A; Vallée-Tourangeau F; Williams LM; Sumich A
    Prostaglandins Leukot Essent Fatty Acids; 2009; 80(2-3):151-6. PubMed ID: 19230637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.